13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 114 holding rows worth $2,847,622,000.
- Accession
- 0001567619-18-001075
- Filer
- CIK 1009258
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 114 entries on the cover page, a total value of $2,847,622,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,847,622,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Mallinckrodt Plc | G5785G107 | SHS | 6,988,248 | $130,401,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 6,609,894 | $109,460,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 5,227,035 | $106,632,000 | thousands by filing date | |
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 99,100,000 | $94,914,000 | thousands by filing date | principal |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,300,365 | $64,108,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 1,742,111 | $62,960,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 1,159,000 | $57,544,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 2,573,305 | $56,664,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,900,000 | $55,941,000 | thousands by filing date | |
| KEMPHARM INC | 488445AB3 | NOTE 5.500 2/0 | 75,000,000 | $55,438,000 | thousands by filing date | principal |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,745,705 | $54,832,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,126,800 | $54,672,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 1,446,633 | $54,639,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 2,498,666 | $47,425,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 191,000 | $45,464,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 229,000 | $42,022,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | 98236JAB4 | NOTE 2.250%11/1 | 31,500,000 | $41,943,000 | thousands by filing date | principal |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,158,841 | $41,521,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 1,048,430 | $40,061,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 562,989 | $39,995,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 324,536 | $39,986,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 296,000 | $39,125,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAB2 | NOTE 3.25011/0 | 40,500,000 | $38,243,000 | thousands by filing date | principal |
| INTERSECT ENT INC | 46071F103 | COM | 1,020,000 | $38,199,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 447,029 | $37,041,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 566,800 | $36,474,000 | thousands by filing date | call |
| TRINITY BIOTECH INVT LTD | 89643QAB4 | NOTE 4.000% 4/0 | 43,000,000 | $35,398,000 | thousands by filing date | principal |
| CVS Health Corporation | 126650100 | COM | 550,000 | $35,393,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 6,063,496 | $34,744,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 1,858,000 | $33,723,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 484,055 | $32,698,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 233,000 | $32,513,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 482,467 | $32,094,000 | thousands by filing date | |
| ENDOCYTE INC | 29269A102 | COM | 2,324,299 | $32,075,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 531,000 | $31,868,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 36,000,000 | $31,598,000 | thousands by filing date | principal |
| GLAUKOS CORP COM | 377322102 | Stock | 754,222 | $30,652,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 741,016 | $30,315,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 474,950 | $30,150,000 | thousands by filing date | |
| NEVRO CORP | 64157FAA1 | BOND | 27,600,000 | $29,913,000 | thousands by filing date | principal |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 350,000 | $29,481,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 262,000 | $29,197,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,124,800 | $26,624,000 | thousands by filing date | |
| K2M GROUP HLDGS INC | 48273JAB3 | NOTE 4.125% 8/1 | 20,000,000 | $26,036,000 | thousands by filing date | principal |
| DFB HEALTHCARE ACQUISTION CO | 23291E208 | UNIT 01/30/2023 | 2,500,000 | $25,375,000 | thousands by filing date | |
| MELINTA THERAPEUTICS INC | 58549G100 | COM | 3,995,806 | $25,373,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 1,801,353 | $24,498,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 1,104,952 | $24,419,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 1,639,000 | $22,208,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 703,600 | $21,995,000 | thousands by filing date | |
| ASSERTIO THERAPEUTICS INC | 249908AA2 | NOTE 2.500% 9/0 | 27,019,000 | $21,952,000 | thousands by filing date | principal |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 609,554 | $21,316,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 1,226,890 | $21,287,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 2,305,773 | $20,959,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 1,080,829 | $20,341,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469AA6 | NOTE | 21,000,000 | $19,342,000 | thousands by filing date | principal |
| MORPHOSYS AG | 617760202 | ADR | 600,000 | $18,204,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 673,000 | $18,097,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,343,181 | $18,025,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 113,000 | $17,735,000 | thousands by filing date | |
| AMERISOURCEBERGEN COR | 000307108 | COMMON | 1,853,998 | $17,372,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 398,194 | $17,361,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,311,000 | $16,899,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 729,948 | $16,687,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 2,722,241 | $16,687,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 168,000 | $16,454,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 398,000 | $15,729,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 165,175 | $15,688,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 165,000 | $15,210,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 146,000 | $14,380,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 1,901,788 | $13,978,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 121,000 | $13,484,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 1,365,143 | $13,419,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,268,945 | $12,956,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 3,491,922 | $12,920,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 649,100 | $12,664,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 287,000 | $12,473,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767EAB8 | NOTE 2.000 8/1 | 16,600,000 | $10,707,000 | thousands by filing date | principal |
| TELIGENT INC NEW | 87960WAA2 | BOND | 9,567,000 | $10,312,000 | thousands by filing date | principal |
| FORTY SEVEN INC | 34983P104 | COM | 600,000 | $9,600,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 628,262 | $9,160,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 2,336,889 | $9,114,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 349,539 | $9,074,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 125,000 | $8,969,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 650,000 | $8,223,000 | thousands by filing date | |
| NUVASIVE INC | 670704AG0 | NOTE 2.250% 3/1 | 7,000,000 | $7,591,000 | thousands by filing date | principal |
| ELECTROCORE INC | 28531P103 | COM | 425,000 | $7,017,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 913,100 | $6,912,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 2,335,000 | $6,842,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 178,806 | $6,839,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 250,000 | $6,698,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 323,807 | $6,586,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 179,381 | $6,391,000 | thousands by filing date | |
| PFENEX INC | 717071104 | COM | 1,129,684 | $6,112,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 6,052,935 | $5,922,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 200,000 | $5,712,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 280,000 | $5,496,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 1,764,889 | $5,224,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 120,000 | $4,260,000 | thousands by filing date | |
| STEADYMED LTD | M84920103 | SHS | 918,120 | $4,132,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 382,700 | $3,808,000 | thousands by filing date | |
| IGI LABORATORIES INC | 449575AB5 | NOTE 3.75012/1 | 3,733,000 | $3,476,000 | thousands by filing date | principal |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 674,002 | $3,377,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 125,000 | $3,326,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,224,899 | $3,001,000 | thousands by filing date | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 1,458,537 | $2,771,000 | thousands by filing date | |
| NUVECTRA CORP | 67075N108 | COM | 131,000 | $2,689,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 708,873 | $2,453,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 117,647 | $2,299,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 80,783 | $2,152,000 | thousands by filing date | |
| EYENOVIA INC | 30234E104 | COM | 300,000 | $1,890,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 48,366 | $1,790,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 233,332 | $1,458,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 1,644,583 | $576,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-18-001075 | this filing | 2018-08-14 | acceptance time not in the bulk data set |